7 News AustraliaANAVEX® Life Sciences Corp.Jul 22, 20151 min readNew pills offer hope for Alzheimer’s sufferers
Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer’s Disease